Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,074
  • Shares Outstanding, K 49,563
  • Annual Sales, $ 96,630 K
  • Annual Income, $ -63,320 K
  • EBIT $ -49 M
  • EBITDA $ -40 M
  • 60-Month Beta 1.34
  • Price/Sales 1.11
  • Price/Cash Flow N/A
  • Price/Book 7.84

Options Overview Details

View History
  • Implied Volatility 162.19% ( -8.27%)
  • Historical Volatility 106.97%
  • IV Percentile 68%
  • IV Rank 45.16%
  • IV High 357.36% on 10/16/24
  • IV Low 1.48% on 01/09/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 723
  • Open Int (30-Day) 710

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.15
  • Number of Estimates 3
  • High Estimate -0.12
  • Low Estimate -0.18
  • Prior Year -0.22
  • Growth Rate Est. (year over year) +31.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.99 +6.02%
on 11/18/24
3.32 -36.42%
on 11/11/24
-0.76 (-26.48%)
since 10/22/24
3-Month
1.99 +6.02%
on 11/18/24
3.32 -36.42%
on 11/11/24
-0.25 (-10.59%)
since 08/22/24
52-Week
1.88 +12.23%
on 05/23/24
6.31 -66.56%
on 03/04/24
-2.04 (-49.16%)
since 11/22/23

Most Recent Stories

More News
Akoya: Q3 Earnings Snapshot

Akoya: Q3 Earnings Snapshot

AKYA : 2.11 (-0.47%)
Akoya Biosciences Reports Third Quarter 2024 Financial Results

AKYA : 2.11 (-0.47%)
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCodeâ„¢ Discovery IO60 and Mouse FFPE IO Panel

AKYA : 2.11 (-0.47%)
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

AKYA : 2.11 (-0.47%)
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

AKYA : 2.11 (-0.47%)
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

AKYA : 2.11 (-0.47%)
Akoya: Q2 Earnings Snapshot

Akoya: Q2 Earnings Snapshot

AKYA : 2.11 (-0.47%)
Stock Index Futures Tread Water Ahead of Key U.S. PPI Data and Powell Remarks

June S&P 500 E-Mini futures (ESM24) are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as investors geared up for crucial U.S. producer inflation data while also awaiting...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
INCY : 71.72 (+1.89%)
INTC : 24.50 (+0.25%)
SQSP : 46.57 (-0.21%)
AMAT : 174.88 (-0.50%)
HD : 420.00 (+2.33%)
ALC.Z.IX : 76.760 (+0.97%)
DHER.D.DX : 38.430 (+3.42%)
RHM.D.DX : 617.800 (+1.88%)
FULC : 3.25 (+9.43%)
FOLD : 9.66 (+1.68%)
Why Shares of Akoya Biosciences Jumped on Tuesday

A rash of insider buying buoyed investor confidence in the medical instrument company.

AKYA : 2.11 (-0.47%)
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications

Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, to develop multiplex-immunohistochemistry diagnostic solutions...

AKYA : 2.11 (-0.47%)
A : 133.84 (+1.35%)

Business Summary

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM)...

See More

Key Turning Points

3rd Resistance Point 2.26
2nd Resistance Point 2.23
1st Resistance Point 2.17
Last Price 2.11
1st Support Level 2.08
2nd Support Level 2.05
3rd Support Level 1.99

See More

52-Week High 6.31
Fibonacci 61.8% 4.62
Fibonacci 50% 4.09
Fibonacci 38.2% 3.57
Last Price 2.11
52-Week Low 1.88

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar